Risk assessment of readmissions following an initial COPD-related hospitalization

International Journal of COPD

Volumn 8, Issue , 2013, Pages 551-559

  Baker, Christine L ^a   Zou, Kelly H ^a   Su, Jun ^b  

^a PFIZER INC   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Chronic obstructive pulmonary disease; Claims data; Hospitalization; Noninterventional study; Readmission; Real world data; Rehospitalization

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR AFFECTING AGENT; OXYGEN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; EMERGENCY CARE; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT CARE; PRIVATE HEALTH INSURANCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNITED STATES;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CLAIMS DATA; HOSPITALIZATION; NONINTERVENTIONAL STUDY; READMISSION; REAL-WORLD DATA; REHOSPITALIZATION;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HEALTH RESOURCES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT READMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84887702169     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S51507     Document Type: Article

References (30)

1. Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III follow-up study. Int J Chron Obstruct Pulmon Dis. 2009;4:137-148.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care. 2002;47:1184-1199.
3. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23:698-702.
4. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med. 2007;101:1305-1312.
5. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-1428.
6. HCUPnet. Agency for Healthcare Research and Quality (1997-2008). Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS). Available from: http://hcupnet.ahrq.gov/HCUPnet.jsp?Id=226284BF0BAE1506&Form=SelLAY&JS=Y&Action=%3E%3ENext%3E%3E&_LAY=Researcher. Accessed February 26, 2013.
7. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012;9:131-141.
8. Kocher RP, Adashi EY. Hospital readmissions and the Affordable Care Act: paying for coordinated quality care. JAMA. 2011;306: 1794-1795.
9. HeatlhCare. gov. Report to Congress: national strategy for quality improvement in health care. Available from: http://www.healthcare.gov/center/reports/quality03212011a.html. Accessed February 14, 2013.
10. National Quality Forum. Measure 1891: Hospital 30-day, all-cause, risk-standardized readmission rate (RSRR) following chronic obstructive pulmonary disease (COPD) hospitalization. Available from: http://www.qualityforum.org/Projects/nr/Pulmonary_Endorsement_Maintenance/1891_30_Day_RSRR_COPD.aspx. Accessed June 13, 2013.
11. CMS. gov. Centers for Medicare and Medicaid Services. Proposed changes to the inpatient PPS for acute care and the long-term care PPS and FY 2012 rates. Available from: http://www.gpo.gov/fdsys/pkg/FR-2011-2005-05/pdf/2011-9644.pdf. Accessed February 14, 2013.
12. Truven Health Analytics. Available from: http://www.truvenhealth.com. Accessed March 25, 2013.
13. Cao Z, Zou KH, Baker CL, et al. Respiratory-related medical expenditure and inpatient utilisation among COPD patients receiving long-acting bronchodilator therapy. J Med Econ. 2011;14:147-158.
14. Stein BD, Charbeneau JT, Lee TA, et al. Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. COPD. 2010;7:164-171.
15. Dalal AA, Shah M, D'Souza AO, Rane P. Costs of inpatient and emergency department care for chronic obstructive pulmonary disease in an elderly Medicare population. J Med Econ. 2010;13:591-598.
16. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
17. Elixhauser AA, Hau DH, Podulka J. Readmission for chronic obstructive pulmonary disease, 2008. HCUP Statistical Brief #121: Healthcare Cost and Utilization Project; 2008. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb121.pdf. Accessed August 15, 2013.
18. Lawlor M, Kealy S, Agnew M, et al. Early discharge care with ongoing follow-up support may reduce hospital readmissions in COPD. Int J Chron Obstruct Pulmon Dis. 2009;4:55-60.
19. Sharma G, Kuo YF, Freeman JL, Zhang DD, Goodwin JS. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med. 2010;170:1664-1670.
20. Nantsupawat T, Limsuwat C, Nugent K. Factors affecting chronic obstructive pulmonary disease early rehospitalization. Chron Respir Dis. 2012;9:93-98.
21. Minakata Y, Sugiura H, Yamagata T, et al. Prevalence of COPD in primary care clinics: correlation with non-respiratory diseases. Intern Med. 2008;47:77-82.
22. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 2005;128:2005-2011.
23. Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care. 2004;27:2478-2484.
24. Antonelli Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10:2794-2800.
25. Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration. 2012;84:17-26.
26. Chen Y, Li Q, Johansen H. Age and sex variations in hospital readmissions for COPD associated with overall and cardiac comorbidity. Int J Tuberc Lung Dis. 2009;13:394-399.
27. Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease. Respir Med. 2011;105:1516-1522.
28. Roberts CM, Stone RA, Lowe D, Pursey NA, Buckingham RJ. Co-morbidities and 90-day outcomes in hospitalized COPD exacerbations. COPD. 2011;8:354-361.
29. McGhan R, Radcliff T, Fish R, et al. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007;132: 1748-1755.
30. Garcia-Polo C, Alcazar-Navarrete B, Ruiz-Iturriaga LA, et al. Factors associated with high healthcare resource utilisation among COPD patients. Respir Med. 2012;106:1734-1742.